- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 211/58 - Nitrogen atoms attached in position 4
Patent holdings for IPC class C07D 211/58
Total number of patents in this class: 848
10-year publication summary
|
53
|
67
|
71
|
51
|
67
|
53
|
51
|
49
|
52
|
11
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
26 |
| ACADIA Pharmaceuticals Inc. | 201 |
22 |
| The Regents of the University of California | 18943 |
19 |
| AstraZeneca AB | 3042 |
16 |
| Boehringer Ingelheim International GmbH | 4629 |
14 |
| Janssen Pharmaceutica N.V. | 3839 |
13 |
| F. Hoffmann-La Roche AG | 7958 |
12 |
| BASF SE | 19740 |
12 |
| Incyte Corporation | 918 |
12 |
| Rigel Pharmaceuticals, Inc. | 613 |
12 |
| Incyte Holdings Corporation | 609 |
11 |
| Helsinn Healthcare SA | 255 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
8 |
| Suzhou Abogen Biosciences Co., Ltd. | 49 |
8 |
| Astellas Pharma Inc. | 1145 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
7 |
| Abbvie Inc. | 1808 |
6 |
| Exigence Technologies Inc. | 14 |
6 |
| Mirati Therapeutics, Inc. | 199 |
6 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
6 |
| Other owners | 616 |